Smoking induces coordinated DNA methylation and gene expression changes in adipose tissue with consequences for metabolic health

Pei-Chien Tsai, Craig A. Glastonbury, Melissa Eliot, Sailalitha Bollepalli, İdil Yet, Juan Castillo‐Fernandez, Elena Carnero‐Montoro, Thomas Hardiman, Tiphaine Martin, Alice Vickers, Massimo Mangino, Kirsten Ward, Kirsi H. Pietiläinen, Panos Deloukas, Tim D. Spector, Ana ViñuelaX, Eric B. Loucks, Miina Ollikainen, Karl T. Kelsey, Kerrin S. Small, Jordana T. BellbioRxiv 2018 · DOI

TL;DR

This study reveals that smoking leaves a systemic "epigenetic signature" in adipose tissue, affecting both DNA methylation and gene expression. These changes are not only widespread across tissues but also linked to cardio-metabolic health risks and can even predict future weight gain after quitting.

What Problem Does This Paper Address?

While smoking's detrimental effects on health are well-established, and its impact on DNA methylation in blood is known, the extent to which these changes extend to metabolically relevant tissues like adipose tissue and influence gene expression and cardio-metabolic health has remained unclear. This paper aims to bridge that gap by comprehensively investigating the coordinated effects of smoking on DNA methylation and gene expression in adipose tissue and their subsequent impact on metabolic health.

Methods

The researchers employed a multi-pronged approach:

  • Genome-wide Association Studies (EWAS & TWAS): They conducted epigenome-wide association studies (EWAS) for DNA methylation and transcriptome-wide association studies (TWAS) for gene expression in adipose tissue samples.
  • Replication and Validation: Findings were replicated in independent cohorts and validated across multiple tissues (blood, skin, lung) to identify tissue-shared effects.
  • Functional Analysis: They explored the association of smoking-related epigenetic changes with cardio-metabolic phenotypes (visceral fat, BMI, etc.) and investigated the predictive power of these changes for future metabolic health outcomes.
  • Smoking Cessation Analysis: The study examined the reversibility of these epigenetic changes after smoking cessation.
  • Genetic Influence Analysis: They investigated the impact of genetic variation on smoking-associated methylation signals.

Datasets

The primary dataset comprised adipose tissue samples from 542 female twins from the TwinsUK cohort (part of the MuTHER study).

Replication and validation datasets included:

  • LEAP cohort: 104 participants (USA) for smoking-DMS replication.
  • Finnish twins: 69 individuals for cardio-metabolic phenotype analysis.
  • Lung cancer subjects: 168 individuals for lung tissue validation.
  • Skin tissue samples: 195 individuals for skin tissue validation.
  • Peripheral blood samples: from 789 and 362 subjects for tissue-shared effects analysis.

Key Insights and Ideas

  • Systemic Epigenetic Footprint: Smoking doesn't just affect the lungs; it leaves a coordinated "epigenetic signature" (changes in DNA methylation and gene expression) across multiple tissues, including metabolically relevant adipose tissue.
  • Adipose Tissue as a Key Player: Adipose tissue is not just a passive bystander but actively responds to smoking, with changes that are linked to metabolic health.
  • Methylation vs. Expression Dynamics: DNA methylation changes appear to be more long-lasting after smoking cessation, while gene expression changes are stronger but shorter-lived.
  • Predictive Power for Future Health: Specific smoking-associated epigenetic markers can predict future weight gain and cardio-metabolic disease risk, even in individuals who quit smoking.
  • Genetic Mediation: Genetic variations influencing smoking behavior and nicotine metabolism may exert their effects, at least in part, through DNA methylation.

Key Results

  • Identified 42 smoking-associated DNA methylation signals (DMS) and 42 smoking-associated gene expression signals (DES) in adipose tissue.
  • Found 5 genes (AHRR, CYP1A1, CYP1B1, CYTL1, F2RL3) with coordinated hypo-methylation and up-regulation in smokers.
  • Demonstrated tissue-shared effects for a proportion of these signals across adipose, blood, skin, and lung tissues.
  • Observed that smoking-DMS in CYP1A1 and NOTCH1 were significantly associated with cardio-metabolic risk factors like visceral fat mass.
  • Showed that BHLHE40 and AHRR methylation and expression levels in current smokers could predict future visceral fat gain after smoking cessation.
  • Replication studies confirmed the consistency of these findings.

Limitations and Future Work

  • Partial Covariate Correction: The study acknowledges limitations in fully accounting for all potential covariates, particularly alcohol consumption, which co-occurs with smoking.
  • Cell Composition Heterogeneity: While efforts were made to account for cell type heterogeneity in adipose tissue, the authors note that this might not fully capture the effect of a heterogeneous cell population as a confounder. Some signals might be cell-subtype specific.
  • Modest Sample Size for Quitting Smokers: The sample size of current smokers who subsequently quit was modest, suggesting the need for replication in larger cohorts to confirm predictive findings.
  • Future Work: The authors suggest further investigation into the mechanisms underlying these smoking-induced epigenetic changes and their role in mediating environmental effects on cardio-metabolic disease risk. They also highlight the need for future studies to assess potential confounding effects, such as cell-specific methylation profiles.

Summary updated

Abstract

Abstract Tobacco smoking is a risk factor for multiple diseases, including cardiovascular disease and diabetes. Many smoking-associated signals have been detected in the blood methylome, but the extent to which these changes are widespread to metabolically relevant tissues, and impact gene expression or cardio-metabolic health, remains unclear. We investigated smoking-associated DNA methylation and gene expression variation in adipose tissue from 542 healthy female twins with available well-characterized cardio-metabolic phenotype profiles. We identified 42 smoking-methylation and 42 smoking-expression signals, where five genes ( AHRR , CYP1A1 , CYP1B1 , CYTL1 , F2RL3 ) were both hypo-methylated and up-regulated in smokers. We replicated and validated a proportion of the signals in blood, adipose, skin, and lung tissue datasets, identifying tissue-shared effects. Smoking leaves systemic imprints on DNA methylation after smoking cessation, with stronger but shorter-lived effects on gene expression. We tested for associations between the observed smoking signals and several adiposity phenotypes that constitute cardio-metabolic disease risk. Visceral fat and android/gynoid ratio were associated with methylation at smoking-markers with functional impacts on expression, such as CYP1A1 , and in signals shared across tissues, such as NOTCH1 . At smoking-signals BHLHE40 and AHRR DNA methylation and gene expression levels in current smokers were predictive of future gain in visceral fat upon smoking cessation. Our results provide the first comprehensive characterization of coordinated DNA methylation and gene expression markers of smoking in adipose tissue, a subset of which link to human cardio-metabolic health and may give insights into the wide ranging risk effects of smoking across the body. Author Summary Tobacco smoking is the strongest environmental risk factor for human disease. Here, we investigate how smoking systemically changes methylome and transcriptome signatures in multiple tissues in the human body. We observe strong and coordinated epigenetic and gene expression changes in adipose tissue, some of which are mirrored in blood, skin, and lung tissue. Smoking leaves a strong short-lived impact on gene expression levels, while methylation changes are long-lasting after smoking cessation. We investigated if these changes observed in a metabolically-relevant (adipose) tissue had impacts on human disease, and observed strong associations with cardio-metabolic disease traits. Some of the smoking signals could predict future gain in obesity and cardio-metabolic disease risk in current smokers who subsequently go on to quit smoking. Our results provide novel insights into understanding the widespread health consequence of smoking outside the lung.
BibTeX
@misc{tsai2018smoking,
  author = {Pei-Chien Tsai and Craig A. Glastonbury and Melissa Eliot and Sailalitha Bollepalli and İdil Yet and Juan Castillo‐Fernandez and Elena Carnero‐Montoro and Thomas Hardiman and Tiphaine Martin and Alice Vickers and Massimo Mangino and Kirsten Ward and Kirsi H. Pietiläinen and Panos Deloukas and Tim D. Spector and Ana ViñuelaX and Eric B. Loucks and Miina Ollikainen and Karl T. Kelsey and Kerrin S. Small and Jordana T. Bell},
  title = {{Smoking induces coordinated DNA methylation and gene expression changes in adipose tissue with consequences for metabolic health}},
  year = {2018},
  doi = {10.1101/353581},
  howpublished = {bioRxiv},
}

Loading related content...

Figure